Researchers from Cleveland Clinic and IBM Unveil AI Strategy for Immunotherapy Targets

Cleveland Clinic and IBM Team Up to Advance Immunotherapy Research through AI

Researchers from Cleveland Clinic and IBM have collaborated to develop a strategy for identifying new targets for immunotherapy using artificial intelligence (AI). This groundbreaking research marks the first peer-reviewed publication from their Discovery Accelerator partnership, which aims to drive advancements in healthcare and life sciences.